Crizotinib v. DMSO in SW480 cells

SRP096656

Homo sapiens

6 Downloadable Samples

Illumina HiSeq 2000

Submitter Supplied Information

Description

SW480 cells were treated with 2uM crizotinib for 72h (versus DMSO) Overall design: Examination of differential up- or down-regulated genes after crizotinib treatment

PubMed ID

28437395

Publication Title

Global survey of the immunomodulatory potential of common drugs.

Total Samples

Submitter’s Institution

No associated institution

Authors

Vladimer GI, Snijder B, Krall N, Bigenzahn JW, Huber KVM, Lardeau CH, Sanjiv K, Ringler A, Berglund UW, Sabler M, de la Fuente OL, Knöbl P, Kubicek S, Helleday T, Jäger U, Superti-Furga G

Source Repository

Sequence Read Archive (SRA)

Alternate Accession IDs

GSE93124

No rows found